Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/AKT signaling pathway: An experimental study

Asian Pacific Journal of Tropical Medicine

Volumn 10, Issue 5, 2017, Pages 515-519

  Yang, Yu ^a   Guo, Jia Xiang ^a   Shao, Zhi Qiang ^a   Gao, Jiang Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

AKT; Bladder cancer; Invasion; Matrine; PI3K; Proliferation

Indexed keywords

GELATINASE A; GELATINASE B; MATRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P27;

ARTICLE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPERIMENTAL STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION;

EID: 85019764505     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtm.2017.05.009     Document Type: Article

References (20)

1. Longo, T.A., Gopalakrishna, A., Tsivian, M., Van Noord, M., Rasch, C.R., Inman, B.A., et al. A systematic review of regional hyperthermia therapy in bladder cancer. Int J Hyperth 32:4 (2016), 381–389.
2. Salehiniya, H., Ghobadi Dashdebi, S., Rafiemanesh, H., Mohammadian-Hafshejani, A., Enayatrad, M., Time trend analysis of cancer incidence in Caspian Sea, 2004–2009: a population-based cancer registries study (northern Iran). Casp J Intern Med 7:1 (2016), 25–30.
3. Zhang, T., Zhan, H.L., Yang, F., Zhou, X.F., Effect of pirarubicin early and conventional intravesical instillation on serum index of patients with superficial bladder carcinoma. J Hainan Med Univ 21:7 (2015), 991–994.
4. ® Immediate Instillations Study Group, Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study. Chin Med J Engl 126:15 (2013), 2805–2809.
5. Wu, L., Wang, G., Liu, S., Wei, J., Zhang, S., Li, M., et al. Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents. Sci Rep, 6, 2016, 35918, 10.1038/srep35918.
6. Peng, X., Zhou, D., Wang, X., Hu, Z., Yan, Y., Huang, J., Matrine suppresses proliferation and invasion of SGC7901 cells through inactivation of PI3K/Akt/uPA pathway. Ann Clin Lab Sci 46:5 (2016), 457–462.
7. Wu, L., Liu, S., Wei, J., Li, D., Liu, X., Wang, J., et al. Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents. Bioorg Med Chem Lett 26:17 (2016), 4267–4271.
8. Li, K., Chen, X., Liu, C., Gu, P., Li, Z., Wu, S., et al. Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells. Biochem Biophys Res Commun 460:2 (2015), 380–385.
9. Huang, W., Wang, F., Wu, C., Hu, W., Efficacy and safety of pirarubicin combined with hyaluronic acid for non-muscle invasive bladder cancer after transurethral resection: a prospective, randomized study. Int Urol Nephrol 47:4 (2015), 631–636.
10. Peng, Y., Li, L., Huang, M., Duan, C., Zhang, L., Chen, J., Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway inbladder cancer cells. Cell Signal 26:12 (2014), 2782–2792.
11. Smolensky, D., Rathore, K., Cekanova, M., Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro. BMC Cancer, 23(15), 2015, 927.
12. Costa, C., Pereira, S., Lima, L., Peixoto, A., Fernandes, E., Neves, D., et al. Abnormal protein glycosylation and activated PI3K/Akt/mTOR pathway: role in bladder cancer prognosis and targeted therapeutics. PLoS One, 10(11), 2015 e0141253.
13. Matsushima, M., Kikuchi, E., Matsumoto, K., Hattori, S., Takeda, T., Kosaka, T., et al. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model. Int J Oncol 47:1 (2015), 377–383.
14. Houédé, N., Pourquier, P., Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers. Pharmacol Ther 145 (2015), 1–18.
15. Gao, Y., Guan, Z., Chen, J., Xie, H., Yang, Z., Fan, J., et al. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Int J Oncol 47:2 (2015), 690–700.
16. Chen, S., Chen, W., Zhang, X., Lin, S., Chen, Z., Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-κB signal pathway. Int J Oncol 48:4 (2016), 1391–1398.
17. El-Masry, O.S., Al-Sakkaf, K., Brown, B.L., Dobson, P.R., Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: leptin inhibits the effectiveness of AMPK activation. Oncol Rep 34:4 (2015), 1675–1680.
18. Sanguedolce, F., Cormio, A., Bufo, P., Carrieri, G., Cormio, L., Molecular markers in bladder cancer: novel research frontiers. Crit Rev Clin Lab Sci 52:5 (2015), 242–255.
19. Tao, L., Li, Z., Lin, L., Lei, Y., Hongyuan, Y., Hongwei, J., et al. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. Genet Test Mol Biomark 19:10 (2015), 548–555.
20. Wieczorek, E., Jablonowski, Z., Tomasik, B., Konecki, T., Jablonska, E., Gromadzinska, J., et al. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer. Clin Biochem 48:18 (2015), 1235–1240.